We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+5.7%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$7.68B
AUM Growth
+$101M
(+1.3%)
Cap. Flow
-$193M
Cap. Flow
% of AUM
-2.51%
Top 10 Holdings %
Top 10 Hldgs %
17.01%
Holding
1,082
New
298
Increased
225
Reduced
230
Closed
304
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$123M |
| 2 |
CVS Health
CVS
|
+$75.5M |
| 3 |
VMW
VMware, Inc
VMW
|
+$62.2M |
| 4 |
Coca-Cola Europacific Partners
CCEP
|
+$51.2M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$50.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
T-Mobile US
TMUS
|
+$97.3M |
| 2 |
AGN
Allergan Inc
AGN
|
+$79.1M |
| 3 |
Micron Technology
MU
|
+$67M |
| 4 |
HP
HPQ
|
+$65.4M |
| 5 |
Baxter International
BAX
|
+$55.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.38% |
| 2 | Financials | 13.7% |
| 3 | Communication Services | 11.26% |
| 4 | Technology | 9.89% |
| 5 | Industrials | 8.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NFX
126
DELISTED
Newfield Exploration
NFX
| $17M | 0.22% |
+485,351
| New | +$14.7M |
|
127
FMC
FMC
$1.42B
| $16.9M | 0.22% |
341,140
-269,568
| -44% | -$14M |
|
|
OCR
128
DELISTED
OMNICARE INC
OCR
| $16.7M | 0.22% |
217,346
-101,177
| -32% | -$7.69M |
|
129
Abbott
ABT
$180B
| $16.7M | 0.22% |
359,407
-220,880
| -38% | -$10.1M |
|
130
Prosperity Bancshares
PB
$8.77B
| $16.6M | 0.22% |
316,712
+54,124
| +21% | +$2.75M |
|
131
Myriad Genetics
MYGN
$530M
| $16.2M | 0.21% |
+458,080
| New | +$16.4M |
|
132
Elevance Health
ELV
$81.9B
| $16M | 0.21% |
+103,451
| New | +$14.7M |
|
133
Labcorp
LH
$24.3B
| $15.9M | 0.21% |
+146,775
| New | +$15.1M |
|
134
General Dynamics
GD
$105B
| $15.8M | 0.21% |
+116,193
| New | +$15.9M |
|
|
QTS
135
DELISTED
QTS REALTY TRUST, INC.
QTS
| $15.8M | 0.21% |
+433,076
| New | +$16M |
|
|
SCHW
136
Charles Schwab
SCHW
$177B
| $15.6M | 0.2% |
514,046
+292,475
| +132% | +$8.48M |
|
137
Molson Coors Class B
TAP
$7.68B
| $15.6M | 0.2% |
209,682
+202,169
| +2,691% | +$15.2M |
|
|
ANAC
138
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
| $15.5M | 0.2% |
268,475
+70,676
| +36% | +$3M |
|
139
Heartland Express
HTLD
$1.11B
| $15.1M | 0.2% |
634,239
+538,033
| +559% | +$13.6M |
|
|
PRE
140
DELISTED
PARTNERRE LTD
PRE
| $15M | 0.2% |
131,317
+121,893
| +1,293% | +$14M |
|
141
Criteo
CRTO
$1.03B
| $14.7M | 0.19% |
373,031
-45,237
| -11% | -$1.88M |
|
|
IDTI
142
DELISTED
Integrated Device Technology I
IDTI
| $14.6M | 0.19% |
+727,353
| New | +$14.3M |
|
|
CLR
143
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $14.5M | 0.19% |
332,055
+12,106
| +4% | +$515K |
|
144
Diamondrock Hospitality Co
DRH
$2.63B
| $14.5M | 0.19% |
1,025,354
-392,243
| -28% | -$5.75M |
|
|
AMAG
145
DELISTED
AMAG Pharmaceuticals
AMAG
| $14.5M | 0.19% |
264,411
+37,667
| +17% | +$1.8M |
|
146
H.B. Fuller
FUL
$3B
| $14.4M | 0.19% |
335,937
| – | – |
|
|
CMA
147
DELISTED
Comerica
CMA
| $14.4M | 0.19% |
318,176
-38,581
| -11% | -$1.72M |
|
148
Northrop Grumman
NOC
$77B
| $13.8M | 0.18% |
86,005
+58,956
| +218% | +$9.42M |
|
149
Charter Communications
CHTR
$14.7B
| $13.6M | 0.18% |
+70,679
| New | +$12.3M |
|
150
Cisco
CSCO
$450B
| $13.3M | 0.17% |
483,279
+374,007
| +342% | +$10.5M |
|
Similar funds
Marshall Wace's Q1 2015 Portfolio in Review
As of Q1 2015, Marshall Wace held 1,082 positions worth $7.68B, up 1.3% from $7.57B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Marshall Wace's Q1 2015 filing shows 298 new, 225 increased, 230 reduced and 304 closed positions. Its largest new stake was Viatris: 845,509 shares worth $50.2M. The largest sale was T-Mobile US, an estimated $97.3M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 18% a quarter earlier, followed by Financials and Communication Services.
- Marshall Wace's largest Q1 2015 buy was Viatris: 845,509 shares worth $50.2M.
- Marshall Wace added most to Allergan plc in Q1 2015, an estimated $123M increase.
- Marshall Wace's biggest Q1 2015 reduction was T-Mobile US, cutting an estimated $97.3M.
- Marshall Wace fully exited Allergan Inc in Q1 2015, selling an estimated $79.1M.
- Marshall Wace's ten largest holdings make up 17% of its $7.68B portfolio in Q1 2015.
- Marshall Wace opened 298 new positions and closed 304 in Q1 2015.
- Marshall Wace's portfolio value rose 1.3% quarter-over-quarter to $7.68B.
Based on Marshall Wace's 13F filing for Q1 2015, filed 11 May 2015.